Ascorbate improves circulation in postural tachycardia syndrome

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 301, Issue 3, 2011, Pages

  Stewart, Julian M ^a   Ocon, Anthony J ^a   Medow, Marvin S ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Free radicals; Vasoconstriction

Indexed keywords

ASCORBIC ACID; NITRIC OXIDE; RINGER SOLUTION;

ADULT; ARTICLE; CIRCULATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEART INDEX; HEMODYNAMIC MONITORING; HUMAN; MALE; OXIDATIVE STRESS; PLETHYSMOGRAPHY; POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME; PRIORITY JOURNAL; VASOCONSTRICTION;

ADMINISTRATION, CUTANEOUS; ADULT; ANALYSIS OF VARIANCE; ANTIOXIDANTS; ASCORBIC ACID; BLOOD CIRCULATION; FEMALE; FOREARM; HEMODYNAMICS; HUMANS; INFUSIONS, INTRAVENOUS; LASER-DOPPLER FLOWMETRY; LEG; MALE; MICRODIALYSIS; NITRIC OXIDE; OXIDATIVE STRESS; POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME; SKIN; TIME FACTORS; TREATMENT OUTCOME; VASCULAR CAPACITANCE; VASCULAR RESISTANCE; VASOCONSTRICTION; YOUNG ADULT;

EID: 80052308824     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00018.2011     Document Type: Article

References (52)

1. Bonyhay I, Freeman R. Sympathetic neural activity, sex dimorphism, and postural tachycardia syndrome. Ann Neurol 61: 332-339, 2007.
2. Brookes ZL, Kaufman S. Myogenic responses and compliance of mesenteric and splenic vasculature in the rat. Am J Physiol Regul Integr Comp Physiol 284: R1604-R1610, 2003.
3. Frei B, England L, Ames BN. Ascorbate is an outstanding antioxidant in human blood plasma. Proc Natl Acad Sci USA 86: 6377-6381, 1989.
4. Fu Q, Vangundy TB, Galbreath MM, Shibata S, Jain M, Hastings JL, Bhella PS, Levine BD. Cardiac origins of the postural orthostatic tachycardia syndrome. J Am Coll Cardiol 55: 2858-2868, 2010.
5. Fu Q, VanGundy TB, Shibata S, Auchus RJ, Williams GH, Levine BD. Menstrual cycle affects renal-adrenal and hemodynamic responses during prolonged standing in the postural orthostatic tachycardia syndrome. Hypertension 56: 82-90, 2010.
6. Furlan R, Jacob G, Snell M, Robertson D, Porta A, Harris P, Mosqueda-Garcia R. Chronic orthostatic intolerance: a disorder with discordant cardiac and vascular sympathetic control. Circulation 98: 2154-2159, 1998.
7. Gamble J, Christ F, Gartside IB. Mercury in silastic strain gauge plethysmography for the clinical assessment of the microcirculation. Postgrad Med J 68, Suppl 2: S25-S33, 1992.
8. Gamble J, Christ F, Gartside IB. Human calf precapillary resistance decreases in response to small cumulative increases in venous congestion pressure. J Physiol 507: 611-617, 1998.
9. Gao L, Wang W, Li YL, Schultz HD, Liu D, Cornish KG, Zucker IH. Sympathoexcitation by central ANG II: roles for AT1 receptor upregulation and NAD(P)H oxidase in RVLM. Am J Physiol Heart Circ Physiol 288: H2271-H2279, 2005.
10. Geddes LA, Baker LE. Detection of physiological events by impedance. In: Principles of Applied Biomedical Instrumentation. New York: Wiley, 1989, p. 594-600.
11. Griendling KK, Ushio-Fukai M. Reactive oxygen species as mediators of angiotensin II signaling. Regul Pept 91: 21-27, 2000.
12. Grossmann M, Dobrev D, Himmel HM, Ravens U, Kirch W. Ascorbic acid-induced modulation of venous tone in humans. Hypertension 37: 949-954, 2001.
13. Hanna IR, Taniyama Y, Szocs K, Rocic P, Griendling KK. NAD(P)H oxidase-derived reactive oxygen species as mediators of angiotensin II signaling. Antioxid Redox Signal 4: 899-914, 2002.
14. Harrison DG, Cai H, Landmesser U, Griendling KK. Interactions of angiotensin II with NAD(P)H oxidase, oxidant stress and cardiovascular disease. J Renin Angiotensin Aldosterone Syst 4: 51-61, 2003.
15. Harrison DG, Chen W, Dikalov S, Li L. Regulation of endothelial cell tetrahydrobiopterin pathophysiological and therapeutic implications. Adv Pharmacol 60: 107-132, 2010.
16. Hodges GJ, Chiu C, Kosiba WA, Zhao K, Johnson JM. The effect of microdialysis needle trauma on cutaneous vascular responses in humans. J Appl Physiol 106: 1112-1118, 2009.
17. Holowatz LA, Kenney WL. Local ascorbate administration augments NO-and non-NO-dependent reflex cutaneous vasodilation in hypertensive humans. Am J Physiol Heart Circ Physiol 293: H1090-H1096, 2007.
18. Hu TM, Chen YJ. Nitrosation-modulating effect of ascorbate in a model dynamic system of coexisting nitric oxide and superoxide. Free Radic Res 44: 552-562, 2010.
19. Huang A, Vita JA, Venema RC, Keaney JF Jr. Ascorbic acid enhances endothelial nitric-oxide synthase activity by increasing intracellular tetrahydrobiopterin. J Biol Chem 275: 17399-17406, 2000.
20. Jablonski KL, Seals DR, Eskurza I, Monahan KD, Donato AJ. Highdose ascorbic acid infusion abolishes chronic vasoconstriction and restores resting leg blood flow in healthy older men. J Appl Physiol 103: 1715-1721, 2007.
21. Jacob G, Robertson D, Mosqueda-Garcia R, Ertl AC, Robertson RM, Biaggioni I. Hypovolemia in syncope and orthostatic intolerance role of the renin-angiotensin system. Am J Med 103: 128-133, 1997.
22. Kar S, Gao L, Zucker IH. Exercise training normalizes ACE and ACE2 in the brain of rabbits with pacing-induced heart failure. J Appl Physiol 108: 923-932, 2010.
23. Kellogg DL Jr, Liu Y, Kosiba IF, O'Donnell D. Role of nitric oxide in the vascular effects of local warming of the skin in humans. J Appl Physiol 86: 1185-1190, 1999.
24. Kirsch M, de Groot H. Ascorbate is a potent antioxidant against peroxynitrite-induced oxidation reactions. Evidence that ascorbate acts by re-reducing substrate radicals produced by peroxynitrite. J Biol Chem 275: 16702-16708, 2000.
25. Kuzkaya N, Weissmann N, Harrison DG, Dikalov S. Interactions of peroxynitrite with uric acid in the presence of ascorbate and thiols: implications for uncoupling endothelial nitric oxide synthase. Biochem Pharmacol 70: 343-354, 2005.
26. Landmesser U, Dikalov S, Price SR, McCann L, Fukai T, Holland SM, Mitch WE, Harrison DG. Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. J Clin Invest 111: 1201-1209, 2003.
27. Laursen JB, Somers M, Kurz S, McCann L, Warnholtz A, Freeman BA, Tarpey M, Fukai T, Harrison DG. Endothelial regulation of vasomotion in apoE-deficient mice: implications for interactions between peroxynitrite and tetrahydrobiopterin. Circulation 103: 1282-1288, 2001.
28. Low PA, Opfer-Gehrking TL, Textor SC, Benarroch EE, Shen WK, Schondorf R, Suarez GA, Rummans TA. Postural tachycardia syndrome (POTS). Neurology 45: S19-S25, 1995.
29. Medow MS, Minson CT, Stewart JM. Decreased microvascular nitric oxide-dependent vasodilation in postural tachycardia syndrome. Circulation 112: 2611-2618, 2005.
30. Minson CT, Berry LT, Joyner MJ. Nitric oxide and neurally mediated regulation of skin blood flow during local heating. J Appl Physiol 91: 1619-1626, 2001.
31. Montgomery LD, Hanish HM, Marker RA. An impedance device for study of multisegment hemodynamic changes during orthostatic stress. Aviat Space Environ Med 60: 1116-1122, 1989.
32. Montgomery LD, Parmet AJ, Booher CR. Body volume changes during simulated microgravity: auditory changes, segmental fluid redistribution, and regional hemodynamics. Ann Biomed Eng 21: 417-433, 1993.
33. Moreau KL, DePaulis AR, Gavin KM, Seals DR. Oxidative stress contributes to chronic leg vasoconstriction in estrogen-deficient postmenopausal women. J Appl Physiol 102: 890-895, 2007.
34. Nicolaides AN. Investigation of chronic venous insufficiency: a consensus statement (France, March 5-9, 1997). Circulation 102: E126-E163, 2000.
35. Nozoe M, Hirooka Y, Koga Y, Araki S, Konno S, Kishi T, Ide T, Sunagawa K. Mitochondria-derived reactive oxygen species mediate sympathoexcitation induced by angiotensin II in the rostral ventrolateral medulla. J Hypertens 26: 2176-2184, 2008.
36. Pacher P, Beckman JS, Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol Rev 87: 315-424, 2007.
37. Press WH, Teukolsky SA, Vetterling WT, Flannery BP. Numerical Recipes in C. Cambridge, UK: Cambridge University Press, 1992, p. 59-70.
38. Sandroni P, Opfer-Gehrking TL, McPhee BR, Low PA. Postural tachycardia syndrome: clinical features and follow-up study. Mayo Clin Proc 74: 1106-1110, 1999.
39. Schondorf R, Low PA. Idiopathic postural orthostatic tachycardia syndrome: an attenuated form of acute pandysautonomia? Neurology 43: 132-137, 1993.
40. Stewart JM, Glover JL, Medow MS. Increased plasma angiotensin II in postural tachycardia syndrome (POTS) is related to reduced blood flow and blood volume. Clin Sci (Lond) 110: 255-263, 2006.
41. Stewart JM, Medow MS, Minson CT, Taneja I. Cutaneous neuronal nitric oxide is specifically decreased in postural tachycardia syndrome. Am J Physiol Heart Circ Physiol 293: H2161-H2167, 2007.
42. Stewart JM, Montgomery LD. Regional blood volume and peripheral blood flow in postural tachycardia syndrome. Am J Physiol Heart Circ Physiol 287: H1319-H1327, 2004.
43. Stewart JM, Ocon AJ, Clarke D, Taneja I, Medow MS. Defects in cutaneous angiotensin-converting enzyme 2 and angiotensin-(1-7) production in postural tachycardia syndrome. Hypertension 53: 767-774, 2009.
44. Stewart JM, Taneja I, Glover J, Medow MS. Angiotensin II type 1 receptor blockade corrects cutaneous nitric oxide deficit in postural tachycardia syndrome. Am J Physiol Heart Circ Physiol 294: H466-H473, 2008.
45. Stewart JM, Taneja I, Medow MS. Reduced body mass index is associated with increased angiotensin-II in young women with postural tachycardia syndrome. Clin Sci (Lond) 113: 449-457, 2007.
46. Stewart JM, Taneja I, Raghunath N, Clarke D, Medow MS. Intradermal angiotensin II administration attenuates the local cutaneous vasodilator heating response. Am J Physiol Heart Circ Physiol 295: H327-H334, 2008.
47. Streeten DH. Pathogenesis of hyperadrenergic orthostatic hypotension. Evidence of disordered venous innervation exclusively in the lower limbs. J Clin Invest 86: 1582-1588, 1990.
48. Streeten DH, Anderson GH Jr, Richardson R, Thomas FD. Abnormal orthostatic changes in blood pressure and heart rate in subjects with intact sympathetic nervous function: evidence for excessive venous pooling. J Lab Clin Med 111: 326-335, 1988.
49. Touyz RM, Schiffrin EL. Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells. Pharmacol Rev 52: 639-672, 2000.
50. Wilkins BW, Martin EA, Roberts SK, Joyner MJ. Preserved reflex cutaneous vasodilation in cystic fibrosis does not include an enhanced nitric oxide-dependent mechanism. J Appl Physiol 102: 2301-2306, 2007.
51. Wolin MS. Interactions of oxidants with vascular signaling systems. Arterioscler Thromb Vasc Biol 20: 1430-1442, 2000.
52. Zucker IH. Brain angiotensin II: new insights into its role in sympathetic regulation. Circ Res 90: 503-505, 2002.